Učitavanje...
DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
BACKGROUND: Deoxycytidine kinase (DCK), an enzyme in the nucleoside biosynthetic pathway, can affect the development of immune cells. However, the relationships between the expression of DCK, patient prognosis, and tumor-infiltrating immune cells (TIICs) in hepatocellular carcinoma (HCC) are still u...
Spremljeno u:
| Izdano u: | World J Surg Oncol |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7372783/ https://ncbi.nlm.nih.gov/pubmed/32690026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-020-01953-1 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|